spacer
The Healthcare Sales & Marketing Network celebrates 24 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  ARIA  

 HSMN NewsFeed - 12 Jul 2022
Accuray CyberKnife(R) System Real World Data and Clinical Studies Show Benefits in Treatment of Neurological Indications
Devices Oncology Neurosurgery
 HSMN NewsFeed - 6 Jul 2022
Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Maria Törnsén
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jul 2022
Lyra Therapeutics Announces Appointment of Richard Nieman, MD, as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Apr 2022
Lantern Pharma's Board of Directors Names Maria Maccecchini, Ph.D. as a Director Nominee to Lantern's Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Apr 2022
Lyra Therapeutics Announces Closing of $100.5 Million Private Placement
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Mar 2022
PainTEQ Appoints Two New Vice Presidents
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 7 Mar 2022
Lyra Therapeutics Appoints Jim Tobin to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jan 2022
Lyra Therapeutics Announces Initiation of LYR-210 Pivotal Phase 3 ENLIGHTEN Program in Surgically Naďve Chronic Rhinosinusitis Patients
Devices Drug Delivery
 HSMN NewsFeed - 13 Jan 2022
PANTHERx Rare(R) Selected by Xeris Pharmaceuticals to Distribute Recorlev(R) (levoketoconazole) for the Treatment of Endogenous Hypercortisolemia in Adult Patients with Cushing's Syndrome
Biopharmaceuticals Distribution
 HSMN NewsFeed - 13 Dec 2021
Hyperfine Appoints New Board of Directors
Devices Radiology Personnel
 HSMN NewsFeed - 24 Nov 2021
ViewRay Announces MRIdian MR-Guided Radiation Therapy Surpasses 2,300 Pancreatic Cancer Patients Treated Worldwide
Devices Oncology
 HSMN NewsFeed - 20 Oct 2021
FDA Expands Approval of Dupixent(R) (dupilumab) to Include Children Aged 6 to 11 Years with Moderate-to-severe Asthma
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Oct 2021
Aspaveli(R) (pegcetacoplan) receives positive CHMP opinion for treatment of PNH
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 Jun 2021
First Procedure in the World with Medtronic Hugo(TM) Robotic-Assisted Surgery System Performed at Clínica Santa Maria in Chile
Devices Surgery
 HSMN NewsFeed - 23 Mar 2021
Poseida Therapeutics Announces Carl June, M.D., to Chair Immuno-Oncology Scientific Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Mar 2021
VLP Therapeutics raises $16M Series A for cancer treatment vaccine R&D
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 17 Dec 2020
FDA Approves GSK's BENLYSTA as the First Medicine for Adult Patients with Active Lupus Nephritis in the US
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Dec 2020
Novartis announces FDA approval of Xolair(R) (omalizumab) for adults with nasal polyps
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Aug 2020
Smith & Nephew Launches ARIA Care Management Platform for Patients and Providers
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 15 Jul 2020
Edwards' KONECT RESILIA Aortic Valved Conduit Receives FDA Approval For Complex Aortic Valve Surgeries
Devices Cardiology Surgery FDA
 HSMN NewsFeed - 19 Jun 2020
Dupixent(R) (dupilumab) Approved in China for Adults with Moderate-to-Severe Atopic Dermatitis
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 1 Jun 2020
Lilly's Taltz(R) (ixekizumab) is the First IL-17A Antagonist to Receive U.S. FDA Approval for the Treatment of Non-Radiographic Axial Spondyloarthritis (nr-axSpA)
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Apr 2020
FoRx Therapeutics AG Raises EUR 10 Million Seed Round and Becomes First Company to Develop a Pipeline of Drugs Targeting DNA Replication Stress for Cancer
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 30 Mar 2020
Lilly's Taltz(R) (ixekizumab) Receives U.S. FDA Approval for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 21 Jan 2020
Onkos Surgical(R) partners with Integrum(R) to expand US market for the OPRA(TM) Implant System; a revolutionary osseointegration and bone-anchored prosthetic technology
Devices Orthopaedic
 HSMN NewsFeed - 12 Dec 2019
European Commission Approves EVENITY(R) (romosozumab) For The Treatment Of Severe Osteoporosis In Postmenopausal Women At High Risk Of Fracture
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 12 Nov 2019
ACR 2019: Lilly Presents 52-Week Head-to-Head (SPIRIT-H2H) Data from Taltz(R) (ixekizumab) Versus Humira(R) (adalimumab) Trial in Psoriatic Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 12 Nov 2019
ACR 2019: Lilly Presents Positive New Data from COAST-X, a Phase 3 Study of Taltz(R) (ixekizumab) in Patients with Non-Radiographic Axial Spondyloarthritis
Biopharmaceuticals
 HSMN NewsFeed - 24 Oct 2019
Amgen To Make Repatha(R) (evolocumab) Available Exclusively At Its Lower List Price Option In 2020
Biopharmaceuticals Cardiology Reimbursement
 HSMN NewsFeed - 18 Oct 2019
EVENITY(R) (Romosozumab) Receives Positive CHMP Opinion For The Treatment Of Severe Osteoporosis In Postmenopausal Women At High Risk Of Fracture
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 3 Oct 2019
New Head-to-Head Data Show Taltz(R) (ixekizumab) Superiority versus TREMFYA(R) (guselkumab) in People with Moderate to Severe Plaque Psoriasis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 26 Aug 2019
Lilly Receives U.S. FDA Approval for Taltz(R) (ixekizumab) for the Treatment of Active Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis)
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Jul 2019
Three Radiotherapy Centers in Serbia Standardize on Varian Solution for Cancer Treatment Planning
Devices Oncology
 HSMN NewsFeed - 12 Jul 2019
Lilly's OVERCOME Observational Study Reveals Inconsistent and Sub-Optimal Treatment Landscape for Migraine
Biopharmaceuticals Neurology
 HSMN NewsFeed - 28 Jun 2019
Amgen and UCB Provide Regulatory Update on Status of EVENITY(TM) (romosozumab) in the EU
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Jun 2019
Bracco Imaging Expands Portfolio of Personalized Diagnostics With the Acquisition of Blue Earth Diagnostics
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 14 Jun 2019
Lilly Presents Positive Results for Taltz(R) (ixekizumab) vs. Humira(R) (adalimumab) in a Head-to-Head (SPIRIT-H2H) Superiority Study in Patients with Active Psoriatic Arthritis at the European Congress of Rheumatology
Biopharmaceuticals
 HSMN NewsFeed - 11 Jun 2019
Lilly to Present 5-Year Sustained Efficacy and Safety Results for Taltz(R) (ixekizumab) in Patients with Plaque Psoriasis at the World Congress of Dermatology
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 31 May 2019
Iovance Biotherapeutics Expands Partnership with WuXi Advanced Therapies Business
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 May 2019
Varian and Shandong Cancer Hospital Form Proton Therapy Clinical Application and Research Partnership in China
Devices Oncology
 HSMN NewsFeed - 30 Apr 2019
South Africa Hospital Delivers HDR Brachytherapy Cancer Treatments with Varian Bravos Afterloader System
Devices Oncology
 HSMN NewsFeed - 24 Apr 2019
Xstrahl Spotlights Full Range of X-Ray Therapy and Radiation Research Systems at ESTRO 2019
Devices Oncology
 HSMN NewsFeed - 9 Apr 2019
Alkermes Announces Positive Topline Results From Innovative Study of ARISTADA(R) and INVEGA SUSTENNA(R) for the Treatment of Schizophrenia
Biopharmaceuticals
 HSMN NewsFeed - 13 Feb 2019
Bausch & Lomb Receives 510(k) Clearance For Use Of The Tangible(R) Hydra-PEG(R) Custom Contact Lens Coating Technology On Several Of Its Boston(R) Gas Permeable Lens Materials And Zenlens(TM) Family Of Scleral Lenses
Devices Ophthalmology FDA
 HSMN NewsFeed - 17 Dec 2018
Lilly Announces Positive Top-Line Results for Taltz(R) (ixekizumab) vs. Humira(R) (adalimumab) in a Head-to-Head (SPIRIT-H2H) Superiority Study in Patients with Active Psoriatic Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 12 Dec 2018
Magnetic Insight Raises $18M to Support Commercial Growth of Magnetic Particle Imaging in Cell Therapy, Vascular and Oncology Applications
Devices Radiology Venture Capital Personnel
 HSMN NewsFeed - 14 Nov 2018
Lilly Submits New Drug Application to the FDA for Lasmiditan for Acute Treatment of Migraine, Receives Breakthrough Therapy Designation for Emgality(TM) (galcanezumab-gnlm) for Prevention of Episodic Cluster Headache
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 10 Oct 2018
bioAffinity Licenses CyPath(R) Lung to Precision Pathology Services
Diagnostics Oncology Licensing
 HSMN NewsFeed - 10 Sep 2018
Lilly Announces Initiation of IXORA-R Head-to-Head Trial Comparing Taltz(R) and Tremfya(R) in Patients with Moderate-to-Severe Plaque Psoriasis
Biopharmaceuticals
 HSMN NewsFeed - 21 Aug 2018
ProMIS Neurosciences Oligomer Selective Antibody Therapeutic for Alzheimer's Disease, PMN310, Shows Potential for Improved Safety Profile in Direct Comparison to Other Amyloid Beta-Directed Antibodies in Clinical Development
Biopharmaceuticals Neurology
 HSMN NewsFeed - 10 Aug 2018
Nuvo Pharmaceuticals(TM) Announces Letter of Intent to Acquire Commercial Products and Infrastructure from Aralez Pharmaceuticals
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 9 Aug 2018
US Food and Drug Administration Approves ARAKODA(TM) (tafenoquine) tablets for oral use; First preventative antimalarial approved in almost two decades
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Aug 2018
Zimmer Biomet Appoints Maria Teresa (Tessa) Hilado and Syed Jafry to Board of Directors
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 28 Jun 2018
Lilly Announces Positive Top-Line Results for Second Phase 3 Study of Taltz(R) (ixekizumab) in Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis) for TNF Inhibitor-Experienced Patients
Biopharmaceuticals
 HSMN NewsFeed - 17 Apr 2018
Xcision Announces Leading Italian Hospital to Acquire GammaPod(TM) Stereotactic Radiotherapy System for Breast Cancer
Devices Oncology
 HSMN NewsFeed - 23 Mar 2018
Amgen Receives Positive CHMP Opinion Recognizing That Repatha(R) (evolocumab) Prevents Heart Attacks And Strokes
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 8 Mar 2018
Cyteir Therapeutics Secures $29 Million Series B to Advance Novel, Molecularly Targeted Therapies for Cancer and Autoimmune Diseases
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 19 Feb 2018
AAD 2018: Treatment with Lilly's Taltz(R) (ixekizumab) Resulted in Improvement in Impact of Genital Psoriasis on Sexual Activity
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 13 Feb 2018
Lilly Announces Positive Top-Line Phase 3 Results for Taltz(R) (ixekizumab) in Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis)
Biopharmaceuticals
 HSMN NewsFeed - 4 Jan 2018
Neurogastrx, Inc. Raises $45M Series A To Bring Lead GI Candidate Through Proof Of Concept
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 6 Dec 2017
Forty Seven Inc. Receives $5 Million Grant from The California Institute for Regenerative Medicine (CIRM) to Support Ongoing Clinical Trial in Acute Myeloid Leukemia
Biopharmaceuticals Regenerative Medicine Oncology
 HSMN NewsFeed - 10 Nov 2017
Amgen Receives Positive CHMP Opinion To Expand Use Of Nplate(R) (romiplostim) In Pediatric Patients With Chronic Immune Thrombocytopenic Purpura
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 8 Nov 2017
Long-Term Use of Lilly's Taltz(R) (ixekizumab) Shows Efficacy Improvements in Psoriatic Arthritis for Patients with Prior Inadequate Response or Intolerance to TNF Inhibitors
Biopharmaceuticals
 HSMN NewsFeed - 6 Nov 2017
Artemis Therapeutics Receives Orphan Drug Designation From U.S. Food And Drug Administration For Artemisone For The Treatment Of Malaria
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Oct 2017
BrainStorm Enrolls First Patients in Phase 3 Trial of NurOwn(R) in ALS
Regenerative Medicine Neurology
 HSMN NewsFeed - 10 Oct 2017
Respicardia's remedē(R) System Receives FDA Approval
Devices Neurology FDA
 HSMN NewsFeed - 29 Sep 2017
Lilly Announces Senior Leadership Appointments for Finance, Research & Development and Manufacturing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jul 2017
FDA Grants Priority Review For Amgen's Supplemental Biologics License Application For Repatha(R) (evolocumab) To Include Data On Reducing Risk Of Cardiovascular Events
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 21 Jul 2017
Brainstorm Awarded $16 Million Non-Dilutive Grant from CIRM in Support of Phase 3 Clinical Trial of NurOwn(R) in ALS
Regenerative Medicine Neurology
 HSMN NewsFeed - 5 Jul 2017
Edwards' INSPIRIS RESILIA Valve Receives FDA Approval
Devices Cardiology FDA
 HSMN NewsFeed - 27 Jun 2017
Mitoconix Bio Raises $20 Million in Series A Funding to Develop Neurodegenerative Disease Therapies
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 24 May 2017
Varian Selected to Provide First Proton Therapy System in Thailand
Devices Oncology
 HSMN NewsFeed - 22 May 2017
BONESUPPORT Announces First Patient Enrolled in FORTIFY Trial With CERAMENT G, a Novel Injectable, Antibiotic-eluting Bone Graft Substitute
Devices Orthopaedic
 HSMN NewsFeed - 10 May 2017
Medtronic First to Receive FDA Approval for MR-Conditional Quadripolar Cardiac Resynchronization Therapy-Pacemakers
Devices Cardiology Radiology FDA
 HSMN NewsFeed - 20 Mar 2017
Landmark Outcomes Study Shows that Repatha(R) (evolocumab) Decreases LDL-C to Unprecedented Low Levels and Reduces Risk of Cardiovascular Events with No New Safety Issues
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 22 Feb 2017
Repatha(R) (Evolocumab) Receives European Commission Approval For New 420 mg Single-Dose Delivery Option
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 3 Feb 2017
Amgen Announces Repatha(R) (Evolocumab) Significantly Reduced The Risk Of Cardiovascular Events In FOURIER Outcomes Study
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 6 Jan 2017
Chimerix Appoints Randall Lanier, PhD as Chief Science Officer, and Roy W. Ware, PhD, MBA as Chief Manufacturing and Technology Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Dec 2016
Aralez Announces Commercial Launch Of BLEXTEN(TM) In Canada
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 16 Nov 2016
PharmaMar Appoints Pascal Besman as Chief Operating Officer of PharmaMar U.S.
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 Oct 2016
Actinium Pharmaceuticals Announces New Hires As Supply Chain Organization Expands To Accommodate Growth
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Sep 2016
Sanaria(R) PfSPZ Vaccine Against Malaria Receives FDA Fast Track Designation
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Sep 2016
IRIDEX Announces Long-Term Glaucoma Efficacy Data for Patients Treated with MicroPulse(R) P3 Probe Technology
Devices Ophthalmology
 HSMN NewsFeed - 29 Aug 2016
New Repatha(R) (evolocumab) Analyses Show Efficacy and Safety Across Risk Groups in Results Presented at ESC Congress 2016
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 13 Jul 2016
CytoSorbents Teams with Medial and Meditrade to Bring CytoSorb(R) to Hungary, Czech Republic, Slovakia, and Poland
Devices Distribution
 HSMN NewsFeed - 25 Apr 2016
Aralez Receives Health Canada Approval For BLEXTEN(TM)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 13 Apr 2016
Impax Announces Availability of EMVERM(TM) (mebendazole) Chewable Tablets, 100 mg
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 4 Feb 2016
Amgen Announces Positive Top-Line Results From Phase 3 GAUSS-3 Trial Of Repatha(R) (Evolocumab) In Statin-Intolerant Patients With High Cholesterol
Biopharmaceuticals
 HSMN NewsFeed - 2 Feb 2016
PharmaMar and Specialised Therapeutics Asia Sign Licensing and Marketing Agreement for APLIDIN(R) (plitidepsin) Covering Several Asian Countries
Biopharmaceuticals Oncology Licensing Distribution
 HSMN NewsFeed - 1 Feb 2016
Abbott to Acquire Alere, Becoming Leader in Point of Care Testing and Significantly Advancing Global Diagnostics Presence
Devices Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 22 Jan 2016
Amgen's Repatha(R) (Evolocumab) Approved As First PCSK9 Inhibitor In Japan For The Treatment Of High Cholesterol
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 Jan 2016
Medical Device Firm Advanced Cooling Therapy Receives 510(k) Clearance from FDA for Second Esophageal Cooling Device to Cool and Warm Patients
Devices FDA
 HSMN NewsFeed - 15 Jan 2016
Novartis receives two new FDA approvals for Cosentyx(R) (secukinumab) to treat patients with ankylosing spondylitis and psoriatic arthritis
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Jan 2016
Impax Receives Approval of EMVERM(TM) (mebendazole) Chewable Tablets, 100 mg
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Jan 2016
Contego Medical Announces European Commercialization of the Paladin(R) Carotid Post-Dilation Balloon with Integrated Embolic Protection(TM) Technology
Devices Interventional Product Launch
 HSMN NewsFeed - 6 Jan 2016
AbbVie's HUMIRA(R) (Adalimumab) Receives First and Only Health Canada Approval for Moderate to Severe Hidradenitis Suppurativa
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 Sep 2015
ImmunoCellular Therapeutics Appoints Mark A. Schlossberg and Gregg A. Lapointe to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Sep 2015
Amgen To Acquire Privately-Held Dezima Pharma
Biopharmaceuticals Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 11 Sep 2015
Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha(TM) (Evolocumab)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 17 Aug 2015
European Commission Grants Marketing Authorisation for Unituxin(TM) (dinutuximab) for the Treatment of Paediatric High-Risk Neuroblastoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 22 Apr 2015
Toshiba Names Maria Piazza Director of Ultrasound Business Unit
Devices Personnel
 HSMN NewsFeed - 5 Mar 2015
Tetraphase Pharmaceuticals Appoints Maria Stahl as Senior Vice President and General Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Dec 2014
CardioKinetix Completes $50 Million Financing and Signs Agreement With Edwards Lifesciences, Including Exclusive Option to Purchase
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 30 Jul 2014
Study Shows that RapidArc(R) Radiosurgery Substantially More Efficient and Comparable in Quality to Gamma Knife(R) in the Treatment of Multiple Brain Metastases
Devices Oncology
 HSMN NewsFeed - 28 Jul 2014
Aqua Pharmaceuticals, LLC Announces the U.S. Food and Drug Administration (FDA) Approval of ACTICLATE(TM) (doxycycline hyclate USP) Tablets, 150 mg and 75 mg
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Jul 2014
Nexavar(R) (sorafenib tablets) now Approved in Canada for the Treatment of Differentiated Thyroid Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 29 May 2014
Mylan Launches Generic Malarone(R) Tablets
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 1 Apr 2014
Inovio Pharmaceuticals Continues Building Its Senior Team With the Appointment of VP of Quality
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 Mar 2014
Genzyme’s Lemtrada(TM) Approved in Brazil for Treatment of Multiple Sclerosis
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 14 Mar 2014
Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe
Biopharmaceuticals Litigation
 HSMN NewsFeed - 28 Jan 2014
Valiant Captivia Thoracic Stent Graft System From Medtronic Receives FDA Approval for Treating Aortic Dissections
Devices Interventional FDA
 HSMN NewsFeed - 6 Jan 2014
MRI Interventions Adds Industry Veteran Maria Sainz as New Board Member
Devices Surgery Radiology Personnel
 HSMN NewsFeed - 19 Dec 2013
Baxter Receives FDA Approval of FEIBA [Anti-Inhibitor Coagulant Complex] for Prophylactic Treatment of Hemophilia A&B Patients with Inhibitors
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Dec 2013
Idenix Pharmaceuticals Files Patent Infringement and Interference Lawsuits Against Gilead Sciences
Biopharmaceuticals Litigation
 HSMN NewsFeed - 21 Oct 2013
Soligenix Announces Appointment of Marco Maria Brughera to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Oct 2013
CardioKinetix Announces First Heart Failure Patients Treated in China With Novel Minimally Invasive Structural Heart Device
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Oct 2013
FDA Files Genentech’s Supplemental Biologics License Application of Xolair(R) (omalizumab) for Chronic Idiopathic Urticaria (CIU)
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 5 Sep 2013
GSK’s MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Melanoma Misses First Co-Primary Endpoint
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Aug 2013
CardioKinetix Announces First Heart Failure Patients Treated in Asia with Minimally Invasive Structural Heart Device
Devices Interventional Cardiology
 HSMN NewsFeed - 19 Aug 2013
Respicardia Announces Enrollment Of First Patients In Pivotal Trial Of The remede(R) System For The Treatment Of Central Sleep Apnea
Devices
 HSMN NewsFeed - 24 Jun 2013
St. Jude Medical Receives CE Mark Approval of MultiPoint Pacing CRT-D
Devices Cardiology Regulatory
 HSMN NewsFeed - 3 Apr 2013
Hitachi Medical Systems America Announces FDA Clearance of Its SCENARIA(TM) Advanced 128-Slice CT System
Devices Radiology FDA
 HSMN NewsFeed - 6 Mar 2013
GI Dynamics Announces Agreement with CMS Medical for Distribution of EndoBarrier(R) Therapy in Brazil
Devices Distribution
 HSMN NewsFeed - 8 Jan 2013
Neurodevice Firm SPR(TM) Therapeutics Raises $5M Series A
Devices Neurology Venture Capital
 HSMN NewsFeed - 20 Nov 2012
Varian Medical Systems to Showcase Advanced Technologies for Treating Cancer with Image-Guided Radiotherapy and Radiosurgery at JASTRO Meeting in Tokyo, Japan
Devices Oncology
 HSMN NewsFeed - 24 Oct 2012
CardioKinetix Announces Data From Latest European Study of Heart Failure Patients With First-of-Its-Kind Percutaneous Treatment
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Oct 2012
CardioKinetix Receives CE Mark Approval for Full Range of Sizes for First-of-Its-Kind Percutaneous Treatment for Heart Failure
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 10 Oct 2012
Genocea Closes $30 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Jul 2012
Delcath Announced Changes To Board Of Directors
Devices Drug Delivery Oncology Personnel
 HSMN NewsFeed - 6 Jul 2012
Court Denies Preliminary Injunction Motion Against Ariosa Diagnostics
Diagnostics Litigation
 HSMN NewsFeed - 29 Jun 2012
Actelion Pharmaceuticals Announces U.S. Food and Drug Administration Approval of Supplemental New Drug Application for Second Generation VELETRI(R) (epoprostenol) for Injection
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 May 2012
Varian Medical Systems to Showcase Oncology Practice Management Products at the 2012 Annual Meeting of the American Society of Clinical Oncology
Devices Oncology
 HSMN NewsFeed - 18 May 2012
CardioKinetix Announces Positive Two-Year Clinical Data for First-of-Its-Kind Minimally Invasive Treatment for Heart Failure
Devices Interventional Cardiology
 HSMN NewsFeed - 8 May 2012
Varian Medical Systems Spotlights Advanced Disease Specific Options at ESTRO 2012 in Barcelona
Devices Oncology
 HSMN NewsFeed - 7 May 2012
Maria Sainz Joins CardioKinetix as President and Chief Executive Officer
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 27 Apr 2012
BIOTRONIK Evia HF-T, World's First MRI-Approved CRT Pacemaker
Devices Cardiology
 HSMN NewsFeed - 17 Apr 2012
Medtronic Announces Global Drug-Eluting Balloon Study
Devices Interventional
 HSMN NewsFeed - 17 Apr 2012
MEDA: Maria Carell Appointed Regional Director for the US
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Feb 2012
Varian Medical Systems to Equip New Proton Treatment Center in Russia
Devices Oncology
 HSMN NewsFeed - 7 Feb 2012
Results from International Trial of Second Sight’s Argus(R) II Retinal Prosthesis System Published in Ophthalmology
Devices Ophthalmology
 HSMN NewsFeed - 27 Jan 2012
KCI Announces New Management Structure
Devices Wound Care Regenerative Medicine Personnel
 HSMN NewsFeed - 23 Jan 2012
Varian Medical Systems Showcases Advanced Radiotherapy Systems for Treating Cancer at 2012 Arab Health Congress and Exhibition
Devices Oncology
 HSMN NewsFeed - 28 Nov 2011
Ascendx Spine(TM) Appoints Pilar Debelius-Kinsey as Sales and Marketing Manager, Europe
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 31 Oct 2011
World-Renowned Cancer Center to Become All-TrueBeam Clinic in Battle Against Cancer
Devices Oncology
 HSMN NewsFeed - 28 Oct 2011
Leading Swedish University Hospital Orders Four TrueBeam Radiotherapy Systems from Varian Medical Systems
Devices Oncology
 HSMN NewsFeed - 11 Oct 2011
Lilly Announces Changes in Senior Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Sep 2011
Varian Medical Systems to Exhibit Product Enhancements Designed to Make Treatment with Varian Radiotherapy and Radiosurgery Systems Faster, Easier, More Accurate, and Cost Effective
Devices Oncology
 HSMN NewsFeed - 8 Sep 2011
Concentric Medical Completes Enrollment in Prospective Multi Center Stentriever Trial for Mechanical Thrombectomy in Stroke
Devices Neurology Interventional
 HSMN NewsFeed - 6 Sep 2011
Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Aug 2011
STRYKER Signs Definitive Agreement to Acquire CONCENTRIC MEDICAL, Inc.
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 25 Jul 2011
Five Leading Academic Hospitals Install the CyberKnife System for Dedicated Radiosurgery
Devices Oncology Neurosurgery
 HSMN NewsFeed - 6 Jun 2011
Merck and ARIAD Announce Presentation of Results of Phase III SUCCEED Trial at American Society of Clinical Oncology Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 May 2011
Study Provides Insight on Medtronic CoreValve(R) System Implants Through Subclavian Approach
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Apr 2011
Cerus Appoints William "Obi" Greenman as President and Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 20 Apr 2011
Aduro BioTech Completes $19.25 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Mar 2011
ARIAD Announces Election to Co-Promote Ridaforolimus in Sarcoma Indication in U.S. upon Approval
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 4 Feb 2011
FDA Approves Makena, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm Birth
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Jan 2011
ARIAD Announces Oral Ridaforolimus Achieved Primary Endpoint of Improved Progression-Free Survival in Patients with Metastatic Soft-Tissue or Bone Sarcomas in the Phase 3 SUCCEED Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Jan 2011
SyncMedical Receives ANVISA Regulatory Approval to Offer Spine and Internal Medicine Products in Brazil
Devices Neurosurgery Orthopaedic Regulatory
 HSMN NewsFeed - 5 Jan 2011
FDA Extends Marketing Exclusivity for INOMAX(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Oct 2010
AngioDynamics Announces Election of Kevin J. Gould to Board of Directors
Devices Personnel
 HSMN NewsFeed - 25 Oct 2010
Major Medical Center in India is Country's First to Offer Fast Arc-based Radiation Therapy Technique for Patients With Cancer
Devices Oncology
 HSMN NewsFeed - 14 Oct 2010
Talecris Biotherapeutics Receives FDA Approval for Gamunex(R)-C
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Oct 2010
Spectrum Pharmaceuticals Announces Appointment of Brett L. Scott as Senior Vice President and Acting Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Sep 2010
Concentric Medical Announces Initiation of the First Stentriever Study in Europe
Devices Neurology Interventional
 HSMN NewsFeed - 10 Sep 2010
FDA Approves New Dosing for FASLODEX(R) (fulvestrant) Injection in Treatment of Metastatic Breast Cancer in HR+ Postmenopausal Women
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 13 Aug 2010
US WorldMeds Acquires Solstice Neurosciences
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 12 Aug 2010
Genocea Biosciences Hires Chip Clark as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jul 2010
Concentric Medical Announces First Stroke Patients Treated With the Merci Retriever(R) in Japan
Devices Neurology
 HSMN NewsFeed - 15 Jul 2010
Ikaria(R) Names Chief Science Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jun 2010
ARIAD Names Timothy P. Clackson to New Position of President of Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jun 2010
St. Jude Medical Announces European Approval of Industry's First Flexible Tip Ablation Catheter
Devices Cardiology Regulatory
 HSMN NewsFeed - 16 Jun 2010
Massachusetts General Hospital and QR Pharma Start a Collaboration on Posiphen(R) and Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 9 Jun 2010
Unigene Appoints New CEO, Ashleigh Palmer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jun 2010
The ARIA(R) Oncology Information System from Varian Medical Systems Now Certified by Surescripts(R) for E-Prescribing
Devices Oncology
 HSMN NewsFeed - 2 Jun 2010
QR Pharma Completes $2.4 Million Seed Financing with Round-Closing Investments from BioAdvance and Angels to Advance Clinical Development of two Alzheimer's Disease Compounds
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 2 Jun 2010
Concentric Medical Announces CE Mark of Aspiration Indication for the DAC(TM) Family of Neurovascular Catheters
Devices Neurology Interventional Regulatory
 HSMN NewsFeed - 1 Jun 2010
Ikaria(R) Names New Head of Research & Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2010
Prostate Cancer Patient First in Spain to Receive Fast and Precise RapidArc(R) Radiotherapy Treatment from Varian
Devices Oncology
 HSMN NewsFeed - 25 May 2010
Multiple European Clinical Registries Show Important Benefits of Medtronic CoreValve(R) Transcatheter Aortic Valve System
Devices Interventional Cardiology
 HSMN NewsFeed - 18 May 2010
AccuVein Signs Exclusive Distribution Agreement in India to Sell Vein Illumination Device
Devices Distribution
 HSMN NewsFeed - 5 May 2010
ARIAD Announces Restructuring of Its Ridaforolimus Collaboration with Merck
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 9 Apr 2010
Cephalon Completes Acquisition of Swiss Pharmaceutical Company Mepha
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 6 Apr 2010
Artepharm Global Announces Addition to Its Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Apr 2010
AMAG Pharmaceuticals and Takeda Pharmaceutical Company Announce Strategic Collaboration for Feraheme(R) in All Therapeutic Indications in Select Ex-US Territories, Including Europe
Biopharmaceuticals Licensing
 HSMN NewsFeed - 25 Feb 2010
Barry Buckland Joins Ancora Pharmaceuticals Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Feb 2010
Covidien Announces New Source of Vital Medical Isotopes
Diagnostics Radiology
 HSMN NewsFeed - 10 Feb 2010
Concentric Medical Announces Key International Regulatory Approvals of Its Trevo(TM) System
Devices Interventional Neurology Regulatory
 HSMN NewsFeed - 1 Feb 2010
Cephalon, Inc. Announces Agreement to Acquire Mepha AG
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 28 Jan 2010
Teva UK Limited Launches Dorzolamide 2% Eye Drops Solution
Biopharmaceuticals Generics Ophthalmology
 HSMN NewsFeed - 20 Jan 2010
SANUWAVE Appoints Dr. Maria Siemionow of Cleveland Clinic to Its Scientific Advisory Board
Devices Regenerative Medicine Personnel
 HSMN NewsFeed - 13 Jan 2010
Octapharma Receives Orphan Drug Exclusivity Approval for wilate(R) - A Replacement Therapy Developed Specifically for von Willebrand Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Jan 2010
Concentric Medical Announces First Patients Treated With Trevo(TM) System in Acute Ischemic Stroke
Devices Neurology Interventional
 HSMN NewsFeed - 23 Dec 2009
Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 28 Sep 2009
CardiAQ Valve Technologies (CVT) Discloses Successful Results of Acute In Vivo Study of Its Novel Transcatheter Mitral Valve Implantation (TMVI) System
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2009
Concentric Medical Launches Full Family of DAC(TM) Neurovascular Catheters
Devices Interventional Neurology
 HSMN NewsFeed - 24 Aug 2009
FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Jul 2009
Monitoring Circulating Tumor Cells With the CellSearch(R) System Can Predict Prognosis in Metastatic Breast Cancer
Diagnostics Oncology
 HSMN NewsFeed - 30 Jun 2009
FDA Approves Feraheme to Treat Iron Deficiency Anemia in Adult Chronic Kidney Disease Patients
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Jun 2009
Epeius Biotechnologies' Rexin-G Receives FDA Fast Track Designation for the Treatment of Pancreatic Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 6 Apr 2009
ARIAD Appoints Former Bristol-Myers Squibb Senior Executive as New Independent Member of Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Feb 2009
Medtronic to Voluntarily Disclose Payments To U.S. Physicians
Devices
 HSMN NewsFeed - 26 Jan 2009
Concentric Medical Reaches Important Stroke Milestone
Devices Neurology Interventional
 HSMN NewsFeed - 8 Jan 2009
Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints
Biopharmaceuticals
 HSMN NewsFeed - 8 Jan 2009
Concentric Medical Closes on $15 Million Financing
Devices Interventional Venture Capital
 HSMN NewsFeed - 17 Dec 2008
Cleveland Clinic Surgeons Perform Nation's First Near-Total Face Transplant
Hospitals & Healthcare Systems
 HSMN NewsFeed - 22 Sep 2008
ARIAD Announces Court Rulings Regarding NF-(kappa)B Patent Lawsuit with Amgen
Biopharmaceuticals Litigation
 HSMN NewsFeed - 12 Sep 2008
ARIAD Announces Merger with ARIAD Gene Therapeutics, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Sep 2008
Ikaria(R) Acquires North American Rights to LUCASSIN(R) From Orphan Therapeutics
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 25 Aug 2008
Ikaria(R) Strengthens Commercial Operations and Human Resources Leadership
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jul 2008
Ikaria(R) Receives FDA Orphan Drug Designation for Inhaled Carbon Monoxide for Delayed Graft Function in Solid Organ Transplants
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Jul 2008
Concentric Medical Launches Next Generation Family of Neurovascular Retrievers
Devices Interventional Neurology
 HSMN NewsFeed - 11 Jul 2008
TREDAPTIVE(TM) (nicotinic acid /laropiprant) Approved in the European Union: New Lipid-Modifying Therapy to Treat LDL-C, HDL-C and Triglycerides
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 8 Jul 2008
Varian Medical Systems Ranked No. 1 in 2008 KLAS Report on Oncology IT Vendors
Devices Oncology
 HSMN NewsFeed - 7 Jul 2008
Xclair(R) Reported to Be Safe and Effective in Study Published in European Journal of Dermatology
Biopharmaceuticals Dermatology Oncology
 HSMN NewsFeed - 1 Jul 2008
Ikaria(R) Strengthens Research & Development Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 May 2008
ARIAD Appoints Former Bristol-Myers Squibb Executive to Lead Corporate Legal and Compliance Functions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 May 2008
Varian Medical Systems to Develop Interface Between the ARIA(TM) Oncology Information System and the Monarch250(TM) Proton Radiotherapy System From Still River Systems
Devices Oncology
 HSMN NewsFeed - 27 May 2008
Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 17 Apr 2008
Eisai Corporation of North America Announces Appointment of Vice President of U.S. Corporate Communications
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Apr 2008
Diasome Pharmaceuticals Announces Series B Financing
Biopharmaceuticals Endocrinology Venture Capital
 HSMN NewsFeed - 11 Apr 2008
Maria Sainz Named President and CEO of Concentric Medical
Devices Personnel
 HSMN NewsFeed - 30 Mar 2008
Drug-Eluting Stents Outperform Bare Stents in Heart Attack
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 17 Mar 2008
Oculus Innovative Sciences Announces Positive Results From Three Abstracts Evaluating the Use of Microcyn(R) Technology in Diabetic Foot Ulcers
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 10 Mar 2008
CryoCor Atrial Fibrillation Study Published in the Journal of the American College of Cardiology
Devices Cardiology
 HSMN NewsFeed - 29 Feb 2008
U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Feb 2008
Sciele Expands Alliance with Sanofi-Aventis to Market Allegra(R) (Fexofenadine HCL) Orally Disintegrating Tablets (ODT) and Allegra(R) Oral Suspension (OS) in the U.S.
Biopharmaceuticals
 HSMN NewsFeed - 19 Feb 2008
FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Feb 2008
ARIAD Appoints Richard W. Pascoe as Chief Operating Officer and Expands Role of Timothy P. Clackson, Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Feb 2008
TomoTherapy Produces 200th Hi-Art(R) Treatment System
Devices Oncology
 HSMN NewsFeed - 4 Jan 2008
CryoCor Reports Publication in Circulation for Treatment of Atrial Fibrillation
Devices Cardiology
 HSMN NewsFeed - 13 Dec 2007
Puricase(R) (pegloticase) Meets Pre-Specified Primary Efficacy Endpoint in Two Replicate Phase 3 Studies
Biopharmaceuticals
 HSMN NewsFeed - 5 Dec 2007
BioAlliance Pharma Acquires the European Commercialization Rights to Pafuramidine for the Treatment of Pneumocystis Carinii Pneumonia
Biopharmaceuticals Licensing
 HSMN NewsFeed - 27 Nov 2007
ARIAD Expands Leadership Team with Three New Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Nov 2007
Through-Wave Ultrasound: Effective, Economical and Ideal for Breast Imaging, Biopsy
Devices
 HSMN NewsFeed - 29 Oct 2007
European Symposium Focuses on Phenoxodiol as an Investigational Drug for Ovarian Cancer Management
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Oct 2007
Orexo Signs Distribution Agreement with Hospira in Asia for Pain Product Rapinyl(TM)
Biopharmaceuticals Distribution
 HSMN NewsFeed - 22 Oct 2007
European Symposium on Phenoxodiol as an Investigational Drug for Ovarian Cancer Management
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Oct 2007
Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis
Biopharmaceuticals Pain Management FDA
 HSMN NewsFeed - 11 Oct 2007
ARIAD Announces Collaboration with ICON Medical to Develop and Commercialize Novel Deforolimus-Eluting Stents
Devices Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 5 Oct 2007
Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 4 Oct 2007
Dr. Martin Mackay Named President of Pfizer Global Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Oct 2007
ARIAD Names Vice President, Clinical Operations to Further Enhance Global Clinical Development Efforts
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Oct 2007
Ikaria Names Executive Vice President of Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Sep 2007
Two New Italian Cancer Centers Select Advanced Radiation Treatment Technology from Elekta
Devices Oncology
 HSMN NewsFeed - 24 Sep 2007
ARIAD Initiates Phase 3 'Succeed' Trial of Oral Deforolimus in Patients with Metastatic Sarcomas
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Sep 2007
Sorin Group: Celebrates 30 Years of Clinical Use of Its Heart Valves and Highlights Activities at EACTS 2007
Devices Cardiology
 HSMN NewsFeed - 10 Sep 2007
Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 10 Sep 2007
ARIAD Announces Agreement with FDA on Special Protocol Assessment for Phase 3 Clinical Trial of Oral Deforolimus
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 27 Aug 2007
Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
Cardiology
 HSMN NewsFeed - 2 Aug 2007
Watson Announces CEO Succession Plan
Biopharmaceuticals
 HSMN NewsFeed - 1 Aug 2007
Deforolimus Approved as Nonproprietary Name for AP23573 - ARIAD's Novel mTOR Inhibitor
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Aug 2007
Orexo Establishes Sales Force in Nordic Markets, by Entering into a Joint Venture with ProStrakan
Biopharmaceuticals
 HSMN NewsFeed - 31 Jul 2007
Varian Medical Systems to Participate in the ASCO Electronic Health Records 2007 Oncology Symposium
Devices Oncology
 HSMN NewsFeed - 26 Jul 2007
Varian Selected for Major Radiotherapy IT Project for Stockholm's Radiotherapy Hospitals
Devices Oncology
 HSMN NewsFeed - 12 Jul 2007
ARIAD and Merck & Co., Inc. Announce Global Collaboration to Jointly Develop and Commercialize AP23573 - ARIAD's Novel mTOR Inhibitor - for Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Jul 2007
CryoLife Establishes Direct Sales Force in Germany
Devices
 HSMN NewsFeed - 28 Jun 2007
Inverness Medical Innovations Announces FDA Clearance of the BinaxNOW(R) Malaria Antigen Detection Rapid Test
Diagnostics FDA
 HSMN NewsFeed - 14 Jun 2007
Critical Biologics Appoints Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jun 2007
ARIAD Announces Appointment of Senior Oncology Executive to Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jun 2007
Washington Hospital Healthcare System First in the United States to Treat Patients Using the New Leksell(R) Gamma Knife Perfexion(TM)
Devices Oncology Neurosurgery
 HSMN NewsFeed - 3 Jun 2007
ARIAD Presents Additional Efficacy Data on AP23573, Novel mTOR Inhibitor, in Phase 2 Advanced Sarcoma Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Jun 2007
Biweekly Xeloda(R) Dosing Regimen is Well Tolerated in Advanced Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 May 2007
FDA Approves XYZAL(R) (Levocetirizine Dihydrochloride) Tablets for the Relief of Seasonal and Year Round Allergies, and Chronic Hives
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 May 2007
Galenea Corp. Appoints Mark Benjamin as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Apr 2007
Newly Published Study Reveals Femara(R) Improves Chances for Harder to Treat Early Breast Cancer Relapse in Postmenopausal Women
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Apr 2007
Merck KGaA and WHO Conclude Partnership to Control Schistosomiasis in Africa
Biopharmaceuticals
 HSMN NewsFeed - 13 Apr 2007
ARIAD files claim against Amgen and Wyeth Alleging Infringement of NF-(kappa)B Patent by Enbrel(R) and Kineret(R)
Biopharmaceuticals Litigation
 HSMN NewsFeed - 23 Mar 2007
David Taylor, MD, Joins VaxInnate as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Mar 2007
Image-Guided Radiotherapy Treatments Begin at New Regional German Cancer Hospital Using Country's First On-Board Imager
Devices Oncology
 HSMN NewsFeed - 7 Mar 2007
The Immune Response Corporation Injects First Patient in Trial of NeuroVax(TM) for Treatment of Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 21 Feb 2007
Abaxis Receives Piccolo Xpress Order From Family Health International (FHI)
Diagnostics
 HSMN NewsFeed - 12 Feb 2007
ARIAD Grants Second Commercial License to Its Patented ARGENT(TM) Cell-Signaling Regulation Technology for Development of New Cancer Therapies
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 6 Feb 2007
Study Showing Benefits of Ultrafiltration Therapy for Heart Failure Patients Published in Journal of American College of Cardiology
Devices Cardiology
 HSMN NewsFeed - 11 Dec 2006
Alliant Pharmaceuticals Signs Co-Promotion Agreement With sanofi-aventis for Allegra(R) (fexofenadine hydrochloride) Oral Suspension
Biopharmaceuticals
 HSMN NewsFeed - 5 Dec 2006
StemCells, Inc. Announces Key Executive Appointments
Regenerative Medicine Personnel
 HSMN NewsFeed - 2 Nov 2006
Ranbaxy Receives Tentative Approval to Manufacture and Market Cetirizine Hydrochloride Syrup
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 2 Nov 2006
ARIAD Presents Expanded Efficacy Data On AP23573, Novel mTOR Inhibitor, In Phase 2 Advanced Sarcoma Cancer Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 Oct 2006
Haemonetics(R) Announces Change to Board of Directors
Devices Personnel
 HSMN NewsFeed - 26 Oct 2006
Pfizer Assists World Health Organization in Search for New Treatments Against Diseases of the Developing World
Biopharmaceuticals
 HSMN NewsFeed - 24 Oct 2006
Misonix Brings Visually Directed HIFU for Prostate Cancer Treatment to Spain
Devices Oncology
 HSMN NewsFeed - 18 Oct 2006
FDA Approves Allegra(R) (fexofenadine hydrochloride) Oral Suspension for Treatment of Seasonal Allergy Symptoms and Chronic Idiopathic Urticaria
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Oct 2006
Stonebridge Pharma and Capellon Pharmaceuticals Announce Co-Promotion Agreement to Market Symax(TM) Duotab (hyoscyamine sulfate) for Irritable Bowel Syndrome
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 11 Oct 2006
ARIAD Grants Commercial License to Its Patented ARGENT(TM) Cell-Signaling Regulation Technology for Development of New Cancer Therapies
Biopharmaceuticals Licensing
 HSMN NewsFeed - 11 Oct 2006
Bellicum Pharmaceuticals Announces Commercial Licensing of ARIAD's ARGENT(TM) Cell-Signaling Regulation Technology for Development of New Cancer Therapies
Biopharmaceuticals Licensing
 HSMN NewsFeed - 5 Oct 2006
HemoSense Names William Dippel as EVP, Operations and Research & Development
Diagnostics Personnel
 HSMN NewsFeed - 2 Oct 2006
GTC Biotherapeutics and LFB Biotechnologies Enter Strategic Collaboration for Recombinant Plasma Proteins and Monoclonal Antibodies
Biopharmaceuticals
 HSMN NewsFeed - 25 Sep 2006
sanofi-aventis and UCB Sign a Co-Promotion Agreement for Xyzal(R) in the United States
Biopharmaceuticals
 HSMN NewsFeed - 25 Sep 2006
UCB and sanofi-aventis sign a co-promotion agreement for Xyzal(R) in the United States
Biopharmaceuticals
 HSMN NewsFeed - 19 Sep 2006
Sorin Group's Annuloplasty Ring MEMO 3D(TM) Obtained CE Mark
Devices Cardiology Regulatory
 HSMN NewsFeed - 13 Sep 2006
MaxCyte Strengthens Leadership Team
Regenerative Medicine Personnel
 HSMN NewsFeed - 13 Sep 2006
Abbott Announces European Launch of Next-Generation Device Designed to Treat Patients at Risk of Stroke
Devices Interventional
 HSMN NewsFeed - 12 Sep 2006
ARIAD Announces Update Regarding NF-(kappa)B Patent Lawsuit with Amgen
Biopharmaceuticals Litigation
 HSMN NewsFeed - 14 Aug 2006
Dennis Goldberg Appointed to CEO of Transport Pharmaceuticals
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Aug 2006
European Commission Approves ATryn(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Jul 2006
UCB, Inc. Submits New Drug Application to FDA for Xyzal(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Jul 2006
Immtech Appoints Carol Ann Olson, MD to Senior Vice President of Pharmaceutical Development and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jul 2006
FDA Approves Lilly's Gemzar(R) For Ovarian Cancer Treatment
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 12 Jul 2006
Mutual Pharmaceutical Company/AR Scientific Launches QUALAQUIN(TM) (quinine sulfate capsules USP, 324 mg)
Biopharmaceuticals
 HSMN NewsFeed - 27 Jun 2006
Halozyme and Baxter Announce Availability of Hylenex for Subcutaneous Delivery of Medications and Fluids
Biopharmaceuticals
 HSMN NewsFeed - 5 Jun 2006
ENTOCORT(R) EC (budesonide) Capsules Recommended by the American Gastroenterology Association as First-Line Therapy for the Treatment of Mild-to-Moderate Crohn's Disease
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 2 Jun 2006
ATryn(R) Receives CHMP Recommendation to Grant Market Authorization
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 4 May 2006
Jury Rules in Favor of ARIAD and Co-Plaintiffs in Lilly NF-(kappa)B Patent Infringement Lawsuit
Biopharmaceuticals Litigation
 HSMN NewsFeed - 2 May 2006
Sorin Group Presents New Heart Valve Prostheses Designed to Restore the Patients' Natural Physiological Conditions
Devices Cardiology
 HSMN NewsFeed - 1 May 2006
Boston Scientific Launches Innovative Technologies for Less-Invasive Coronary Artery Bypass Surgery
Devices Cardiology Surgery
 HSMN NewsFeed - 27 Apr 2006
Medtronic Receives CE Mark for New Carotid Stent and Filter
Devices Interventional Regulatory
 HSMN NewsFeed - 24 Apr 2006
ARIAD Announces Lawsuit Relating to NF-(kappa)B Patent
Biopharmaceuticals Litigation
 HSMN NewsFeed - 13 Apr 2006
Dr. Reddy's Receives USFDA Approval for Fexofenadine Hydrochloride
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 Mar 2006
Humanetics Corporation and Mount Sinai School of Medicine to Begin Clinical Trials of New Alzheimer's Compound
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 21 Feb 2006
Six CT Laser Mammography Studies to be Included in European Congress of Radiology Scientific Sessions
Devices Radiology Oncology
 HSMN NewsFeed - 21 Feb 2006
Signet Laboratories, Inc. and AsymmetRx, Inc. Announce Exclusive Agreement for Distribution of FDA 510(k) Cleared Diagnostic Tests ('Prostate-63') for the Diagnosis of Prostate Cancer Using p63
Diagnostics Oncology Distribution
 HSMN NewsFeed - 14 Feb 2006
ARIAD Initiates First Clinical Trial of Oral AP23573 in Combination with Doxorubicin Chemotherapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Feb 2006
Defibtech Lifeline AED(R) Chosen For 2006 Winter Olympic Games
Devices Cardiology
 HSMN NewsFeed - 8 Feb 2006
Halozyme Therapeutics and Baxter Release Results From the INFUSE-LR Study
Biopharmaceuticals
 HSMN NewsFeed - 7 Feb 2006
Theregen Announces Equity Investment from Guidant Corporation to Develop Anginera(TM) Epicardial Patch
Devices Cardiology Regenerative Medicine
 HSMN NewsFeed - 27 Jan 2006
Barr Says Court Denies Preliminary Injunction to Halt Generic Allegra(R) Sales
Biopharmaceuticals Generics Litigation
Return to NewsFeed  

 Additional items found! 131

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 131 additional stories matching:
ARIA
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.